Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 60 - Any |
Updated: | 2/7/2015 |
Start Date: | April 2013 |
Contact: | Denise D. Montgomery, MT(ASCP) |
Email: | ddmontgomery@umc.edu |
Phone: | 601-815-5374 |
This will be a small study aimed at determining the effects of oral Immulina consumption on
the immune system in elderly individuals.
the immune system in elderly individuals.
Inclusion Criteria:
- Age 60 and older;
- Generally otherwise healthy for age and not taking medications/supplements that could
be expected to affect stress responses and/or impact immune parameters (example -
systemic steroids, beta blockers, antidepressants, anti-anxiety drugs, Echinacea
supplements, ginseng supplements or Spirulina supplements).
Exclusion Criteria:
- Inability to comprehend and speak English;
- Any history of major psychological or psychiatric illness (example - dementia,
psychotic disorder, acute mania, current substance abuse) that may limit participant
cooperation or compromise the integrity of self-reported clinical or psychological
data;
- Presence of a confounding underlying systemic illness which could interfere with
immunological profiles (example - severe cardiovascular, pulmonary, hepatic,
gastrointestinal, renal, neurological, musculoskeletal endocrine , or metabolic
systems; other gross physical impairments; or any history of significant convulsive
disorder). Specifically, patients with congestive heart failure, recent viral or
bacterial illness in the past 3 weeks, chronic kidney disease, thyroid disorder,
autoimmune disease will be excluded.
We found this trial at
1
site
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
Click here to add this to my saved trials